An important development was announced regarding the first patient treated with personalized mRNA cancer vaccine method in Russia. After the treatment process, data regarding the patient's clinical condition was shared.
According to the statement, it was stated that no new tumor formation was observed in the first patient to whom the mRNA cancer vaccine was administered for four months.
Source: BPT
COMMENTS (0)
Community CommentsNo comments yet. Be the first to share your thoughts on this story!